Industries > Healthcare | SupplyChainBrain
Webinars
Podcasts
Videos
Events
Subscribe
Sign In
Logistics
Air Cargo
All Logistics
Facility Location Planning
Freight Forwarding/Customs Brokerage
Global Gateways
Global Logistics
Last Mile Delivery
Logistics Outsourcing
LTL/Truckload Services
Ocean Transportation
Parcel & Express
Rail & Intermodal
Reverse Logistics
Service Parts Management
Transportation & Distribution
Technology
All Technology
Artificial Intelligence
Cloud & On-Demand Systems
Data Management (Big Data/IoT/Blockchain)
ERP & Enterprise Systems
Forecasting & Demand Planning
Global Trade Management
Inventory Planning/Optimization
Product Lifecycle Management
Robotics
Sales & Operations Planning
SC Finance & Revenue Management
SC Planning & Optimization
Supply Chain Visibility
Transportation Management
General SCM
Business Strategy Alignment
Customer Relationship Management
Education & Professional Development
Global Supply Chain Management
Global Trade & Economics
Green Energy
HR & Labor Management
Quality & Metrics
Regulation & Compliance
Sourcing/Procurement/SRM
SC Security & Risk Mgmt
Supply Chains in Crisis
Sustainability & Corporate Social Responsibility
Warehousing
All Warehouse Services
Conveyors & Sortation
Lift Trucks & AGVs
Order Management & Fulfillment
Packaging
RFID, Barcode, Mobility & Voice
Warehouse Automation
Warehouse Management Systems
Industries
Aerospace & Defense
Apparel
Automotive
Chemicals & Energy
Consumer Packaged Goods
E-Commerce/Omni-Channel
Food & Beverage
Healthcare
High-Tech/Electronics
Industrial Manufacturing
Pharmaceutical/Biotech
Retail
Think Tank
Healthcare: Page 50
Novartis CEO's Dilemma: Is $475,000 Too Much for a Leukemia Breakthrough?
Joseph Jimenez, the chief executive of Novartis, is celebrating a triumph. The Food and Drug Administration approved Kymriah, a new treatment for kids with leukemia. But he's also taking heat from all sides over his decision to charge $475,000 for the treatment, and, in a major first, to negotiate deals that charge only patients who go into remission.
Bayer Recalled 1M Alka Seltzer Cartons As Sales in Consumer Health Slid
Bayer - already struggling with falling consumer health sales - is also contending with a recall. It has been retrieving more than a million cartons of its Alka-Seltzer Original.
Production Issues Lead to Global Shortage of Hepatitis B Vaccine
A global shortage of hepatitis B vaccine has developed as both Merck & Co. and GlaxoSmithKline deal with manufacturing issues, leading health agencies in England to ration use to those most at risk.
Drug Company Sues Federal Government to Fend Off Competition From Generics
One of Maryland's largest drug manufacturers is suing the federal government to fend off competition on one of its key drugs, saying its right to exclusively sell the medication should continue an additional three years.
The Generic Drug Industry Has Brought Huge Cost Savings. That May Be Changing.
A decade ago, physicians who treat epilepsy got what seemed like a piece of good news: Eight companies had received federal approval to sell a generic version of an injectable lifesaving drug.
Hard Questions for a Company at the Center of the Opioid Crisis
The immense pay packages bestowed on corporate chieftains are often said to reflect feats of management that enrich company shareholders. An executive's masterly performance justifies the compensation, in other words.
Supply Chain Innovation Is Key to Affordable Healthcare, Report Says
Advanced supply chains could be the key to helping life sciences and healthcare meet increasing demand for services cost, according to a report.
Nevada Has a Drug Problem: Shops Are Running Out of Marijuana
Nevada officials have declared a state of emergency over marijuana: There's not enough of it.
P&G, Cargill Partner to Improve Coconut Oil Supply Chain Transparency
Companies that source coconut oil from the Philippines and Indonesia - the world's two largest producers and exporters of coconut-based products - face several challenges: little or no economies of scale, lack of financing and training resources, and a rigid supply chain all serve to increase the farmers' dependence on middlemen and perpetuates inefficient and unsustainable agricultural practices.
A.I. Starts to Deliver in the Enterprise, at Last
Computers soon could deliver smarter healthcare to patients at Massachusetts General Hospital (MGH).
Drugmakers and Distributors Face Barrage of Lawsuits Over Opioid Epidemic
The companies that manufacture and distribute highly addictive painkillers are facing a barrage of lawsuits for the toll their product has taken on communities across the country as the worst drug epidemic in U.S. history continues to escalate.
U.K. Pharmaceutical Manufacturers Will Be Lumped With India, China Upon Brexit
The European Commission has made clear how it intends to treat the U.K.'s active pharmaceutical ingredient (API) industry after that country gives up its EU membership: just like it treats those from China and India.
Previous Page
Page 50 of 57
Next Page
Sign me up!
Receive the latest supply chain trends, news and analysis from SupplyChainBrain.
Email Address
*
Sign Up
Featured Product
Case Studies
Case Studies
How a Leading U.S. Floral Distribution Company Reduced Warehouse Labor Costs by 45% with RFID
Case Studies
Recycled Tagging Fasteners: Small Changes Make a Big Impact
Case Studies
Enhancing High-Value Electronics Shipment Security with Tive's Real-Time Tracking
Case Studies
Moving Robots Site-to-Site
